Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin

Clinical Biochemistry

Volumn 47, Issue 16-17, 2014, Pages 155-157

  Kavsak, Peter A ^a   Jaffe, Allan S ^b   Hickman, Peter E ^c   Mills, Nicholas L ^d   Humphries, Karin H ^e   McRae, Andrew ^f   Devereaux, P J ^a   Lamy, Andre ^a   Whitlock, Richard ^a   Dhesy Thind, Sukhbinder K ^a   Potter, Julia M ^c   Worster, Andrew ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MAYO CLINIC   (United States)

^c The Australian National University   (Australia)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cancer; Cardiac surgery; Emergency medicine; High sensitivity cardiac troponin; Noncardiac surgery; Research

Indexed keywords

TROPONIN; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ARTICLE; ASSAY; CANADA; CLINICAL DECISION MAKING; CLINICAL PRACTICE; EMERGENCY MEDICINE; FEMALE; HEART INFARCTION; HEART SURGERY; HUMAN; LABORATORY TEST; MALE; MEDICAL RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; METABOLISM; NEOPLASM; PROCEDURES; THORAX SURGERY;

CANADA; EMERGENCY MEDICINE; HUMANS; NEOPLASMS; THORACIC SURGERY; TROPONIN T;

EID: 84908650601     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.10.002     Document Type: Article

References (36)

1. Kavsak P.A., Allen L.C., Apple F.S., Booth R.A., Chan P.C., Delvin E., et al. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays - an update from the Canadian society of clinical chemists (CSCC). Clin Biochem 2011, 44:1273-1277.
2. High-Sensitivity Cardiac Troponin for the Rapid Diagnosis of Acute Coronary Syndrome in the Emergency Department: A Clinical and Cost-Effectiveness Evaluation [Internet] Mar. 2013, Source, Canadian Agency for Drugs and Technologies in Health, Ottawa (ON), [http://www.cadth.ca/en/products/optimal-use/high-sensitivity-troponin].
3. Kavsak P.A., Hill S.A., Supapol W.B., Devereaux P.J., Worster A. Biomarkers for predicting serious cardiac outcomes at 72hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes. Clin Chem 2012, 58:298-302.
4. Kavsak P.A., Wang X., Ko D.T., MacRae A.R., Jaffe A.S. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009, 55:1809-1815.
5. Kavsak P.A., MacRae A.R., Yerna M.J., Jaffe A.S. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009, 55:573-577.
6. Recommendations for the Use of Troponin Assays for Rapid Diagnosis of Acute Coronary Syndrome in the Emergency Department. CADTH Optimal Use Report March 2013, vol. 2 (1B):6.
7. Apple F.S., Jaffe A.S., Collinson P., Mockel M., Ordonez-Llanos J., Lindahl B., et al. On behalf of the International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem Sep. 7 2014, [pii: S0009-9120(14)00656-0]. 10.1016/j.clinbiochem.2014.08.021.
8. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation 2012, 126:2020-2035.
9. Koerbin G., Abhayaratna W.P., Potter J.M., Apple F.S., Jaffe A.S., Ravalico T.H., et al. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem 2013, 46(16-17):1636-1643.
10. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547.
11. Kavsak P.A., Xu L., Yusuf S., McQueen M.J. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem 2011, 57:1146-1153.
12. McQueen M.J., Kavsak P.A., Xu L., Shestakovska O., Yusuf S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clin Biochem 2013, 46:5-9.
13. Omland T., Pfeffer M.A., Solomon S.D., de Lemos J.A., Røsjø H., Šaltyte˙ Benth J., et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013, 61:1240-1249.
14. Nagele P., Brown F., Gage B.F., Gibson D.W., Miller J.P., Jaffe A.S., et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J 2013, 166:325-332.
15. Botto F., Alonso-Coello P., Chan M.T., Villar J.C., Xavier D., Srinathan S., et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology 2014, 120:564-578.
16. Dhesy-Thind S., Kumar V., Snider-McNair A., Shortt C., Mukherjee S.D., Ellis P., et al. Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapy. Clin Chem 2013, 59:327-329.
17. Lenihan D.J. Cardiac biomarkers, cardiotoxicity, and active collaboration: is this the final frontier or the wave we should catch?. J Am Coll Cardiol 2014, 63:817-818.
18. Whitlock R., Teoh K., Vincent J., Devereaux P.J., Lamy A., Paparella D., et al. Rationale and design of the steroids in cardiac surgery trial. Am Heart J 2014, 167:660-665.
19. Shah A.S.V., Griffiths M., Lee K.K., McAlister D.A., Hunter A.L., Cruikshank A., et al. High-sensitivity Cardiac Troponin and the Under Diagnosis of Myocardial Infarction in Women [Abstract]. European Society of Cardiology Congress Report 2013, [http://www.escardio.org/congresses/esc-2013/congress-reports/Pages/711-High-STEACS.aspx# Uon-bvkqiSo, Accessed November 2013].
20. Apple F.S., Jaffe A.S. Men are different than women: it's true for cardiac troponin too. Clin Biochem 2014, 47:867-868.
21. Jaffe A.S., Apple F.S. High-sensitivity cardiac troponin assays: isn't it time for equality?. Clin Chem 2014, 60:7-9.
22. Eggers K.M., Lind L., Venge P., Lindahl B. Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75years of age. Clin Chem 2013, 59:1068-1073.
23. Gore M.O., Seliger S.L., Defilippi C.R., Nambi V., Christenson R.H., Hashim I.A., et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 2014, 63:1441-1448.
24. Jaffe A.S., Moeckel M., Giannitsis E., Huber K., Mair J., Mueller C., et al. In search for the Holy Grail: suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care Jul. 9 2014, [pii: 2048872614541906].
25. Sandoval Y., Thordsen S.E., Smith S.W., Schulz K.M., Murakami M.M., Pearce L.A., et al. Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. Eur Heart J Acute Cardiovasc Care Jun. 25 2014, [pii: 2048872614538411].
26. Kavsak P.A., Ko D.T., Wang X., Macrae A.R., Jaffe A.S. 2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay. Clin Chem 2010, 56:487-489.
27. Kavsak P.A., Ko D.T., Wang X., Macrae A.R., Jaffe A.S. Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort. Clin Chem 2010, 56:1902-1904.
28. Reichlin T., Irfan A., Twerenbold R., Reiter M., Hochholzer W., Burkhalter H., et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011, 124:136-145.
29. Kavsak P.A., Worster A., You J.J., Oremus M., Shortt C., Phan K., et al. Ninety-minute vs 3-h performance of high-sensitivity cardiac troponin assays for predicting hospitalization for acute coronary syndrome. Clin Chem 2013, 59:1407-1410.
30. Simpson A.J., Potter J.M., Koerbin G., Oakman C., Cullen L., Wilkes G.J., et al. Use of observed within-person variation of cardiac troponin in emergency department patients for determination of biological variation and percentage and absolute reference change values. Clin Chem 2014, 60:848-854.
31. Body R., Carley S., McDowell G., Jaffe A.S., France M., Cruickshank K., et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011, 58:1332-1339.
32. Rubini Giménez M., Hoeller R., Reichlin T., Zellweger C., Twerenbold R., Reiter M., et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol 2013, 168:3896-3901.
33. Bandstein N., Ljung R., Johansson M., Holzmann M.J. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014, 63:2569-2578.
34. Kavsak P.A., Worster A. Dichotomizing high-sensitivity cardiac troponin T results and important analytical considerations. J Am Coll Cardiol 2012, 59:1570.
35. Kavsak P.A., Hill S.A., McQueen M.J., Devereaux P.J. Implications of adjustment of high-sensitivity cardiac troponin T assay. Clin Chem 2013, 59:574-576.
36. Wang T.K., Stewart R.A., Ramanathan T., Kang N., Gamble G., White H.D. Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. Eur Heart J Acute Cardiovasc Care 2013, 2:323-333.